Investing.com - BeiGene reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
BeiGene announced earnings per share of $-4.81 on revenue of $91.08M. Analysts polled by Investing.com anticipated EPS of $-4.12 on revenue of $86.28M.
BeiGene shares are up 80.98% from the beginning of the year and are trading at $300.00 , down-from-52-week-high.They are outperforming the Nasdaq which is up 32.52% from the start of the year.
BeiGene follows other major Healthcare sector earnings this month
BeiGene's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Novartis ADR had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of $1.52 on revenue of $12.26B, compared to forecast for EPS of $1.45 on revenue of $12.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar